Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
United States of America, ex rel. et al v. Omnicare, Inc. et al
Case Number:
1:11-cv-00962
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
June 26, 2014
CORRECTED: Omnicare Seals End To Insurer's FCA Suit
Onetime Medicare Part D insurer Fox Rx Inc., under a deal approved Wednesday, will forgo an appeal and pay $100,000 to partly cover the litigation costs of nursing home pharmacy Omnicare Inc. after losing a False Claims Act suit that was attacked as frivolous. (Correction: An earlier story referred mistakenly to the recovered costs as attorneys fees. The error has been corrected.)
-
May 20, 2013
Omnicare Gets FCA Off-Label Prescription Action Trimmed
A Georgia federal judge on Friday trimmed several claims from a False Claims Act suit accusing Omnicare Inc. of charging Medicare for thousands of anti-psychotic drug prescriptions for off-label uses, ruling they weren't backed by evidence or were improperly added to an amended complaint.
-
August 29, 2012
Omnicare Skirts FCA Suit Over Anti-Psychotics Prescriptions
A Georgia federal judge on Wednesday threw out a False Claims Act case accusing Omnicare Inc. of charging Medicare for thousands of prescriptions for anti-psychotic drugs for allegedly off-label uses or charging without receiving proper authorization.